Cargando…
Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients
BACKGROUND: Anthracycline adjuvant therapy has taken a particular role in the treatment of early stage breast cancer with an associated decrease in rates of both relapse and death. Their success however has been limited by their myelosuppression and their well-established risk of cardiac dysfunction...
Autores principales: | Mina, Alain, Rafei, Hind, Khalil, Maya, Hassoun, Yasmine, Nasser, Zeina, Tfayli, Arafat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311428/ https://www.ncbi.nlm.nih.gov/pubmed/25605569 http://dx.doi.org/10.1186/s12885-014-1004-0 |
Ejemplares similares
-
Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy
por: Beaudry, Rhys I., et al.
Publicado: (2019) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017) -
Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study
por: Naja, Farah, et al.
Publicado: (2015) -
Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984) -
Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy
por: Hatse, Sigrid, et al.
Publicado: (2022)